HealthStat Rx Specialty Pharmacy now able to provide new once-daily HIV pill Complera
Thursday, September 01, 2011
Smyrna, GA September 1, 2011- The FDA has approved new once-daily HIV pill Complera. Complera is manufactured by Gilead and is the second complete HIV treatment in a single once- daily pill. Gilead’s Atripla was the first single tablet regimen approved for HIV back in 2006.
Complera is a combination of existing HIV therapies Truvada and Edurant. Complera is approved as a first line treatment for adults with HIV infection who have not yet begun treatment with any other HIV medications. (http://www.webmd.com/hiv-aids/news)
HealthStat Rx, LLC is a full service specialty pharmacy dedicated to serving the needs of patients living with complex chronic health conditions. The company partners with patients, physicians, clinics and healthcare payers to offer innovative patient-centric solutions to effectively manage many different disease states. HealthStat Rx is committed to improving health outcomes by offering specialized care through a variety of pharmacist managed medication programs which include HIV, Hepatitis C, Worker’s Compensation, 340B contract pharmacy and many more.